| - GRCh37:
- Chr17:40690337-40690793
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Pathogenic (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688291-40729741
| MLX, COASY, HSD17B1, NAGLU, PSMC3IP | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689396-40690793
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Pathogenic (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689450
- GRCh38:
- Chr17:42537432
| NAGLU | Y140H | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely pathogenic (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695297
- GRCh38:
- Chr17:42543279
| NAGLU | G425R | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695463
- GRCh38:
- Chr17:42543445
| NAGLU | A480V | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690728
- GRCh38:
- Chr17:42538710
| NAGLU | P240L | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693233
- GRCh38:
- Chr17:42541215
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689397
- GRCh38:
- Chr17:42537379
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695415
- GRCh38:
- Chr17:42543397
| NAGLU | R464Q | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688507
- GRCh38:
- Chr17:42536489
| NAGLU | A73T | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695114
- GRCh38:
- Chr17:42543096
| NAGLU | A364T | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693102
- GRCh38:
- Chr17:42541084
| NAGLU | I300T | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, not provided
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40690437
- GRCh38:
- Chr17:42538419
| NAGLU | M204I | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688678
- GRCh38:
- Chr17:42536660
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688344
- GRCh38:
- Chr17:42536326
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689412
- GRCh38:
- Chr17:42537394
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695646
- GRCh38:
- Chr17:42543628
| NAGLU | R541Q | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695147
- GRCh38:
- Chr17:42543129
| NAGLU | R375C | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688438
- GRCh38:
- Chr17:42536420
| NAGLU | V50L | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695201
- GRCh38:
- Chr17:42543183
| NAGLU | R393C | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690472
- GRCh38:
- Chr17:42538454
| NAGLU | P216H | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693159
- GRCh38:
- Chr17:42541141
| NAGLU | P319L | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695028
- GRCh38:
- Chr17:42543010
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695164
- GRCh38:
- Chr17:42543146
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695846
- GRCh38:
- Chr17:42543828
| NAGLU | E608Q | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688670
- GRCh38:
- Chr17:42536652
| NAGLU | N127S | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690693
- GRCh38:
- Chr17:42538675
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695329
- GRCh38:
- Chr17:42543311
| NAGLU | N435K | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695433
- GRCh38:
- Chr17:42543415
| NAGLU | D470V | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695520
- GRCh38:
- Chr17:42543502
| NAGLU | R499Q | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688329
- GRCh38:
- Chr17:42536311
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688327
- GRCh38:
- Chr17:42536309
| NAGLU | L13F | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Nov 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689559
- GRCh38:
- Chr17:42537541
| NAGLU | Q176R | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688548
- GRCh38:
- Chr17:42536530
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690730
- GRCh38:
- Chr17:42538712
| NAGLU | V241L | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688652
- GRCh38:
- Chr17:42536634
| NAGLU | L121P | Mucopolysaccharidosis, MPS-III-B, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
| Uncertain significance (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40688453
- GRCh38:
- Chr17:42536435
| NAGLU | A55T | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695942
- GRCh38:
- Chr17:42543924
| NAGLU | Q640* | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Nov 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693182
- GRCh38:
- Chr17:42541164
| NAGLU | L327F | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689504
- GRCh38:
- Chr17:42537486
| NAGLU | A158S | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688676
- GRCh38:
- Chr17:42536658
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688462
- GRCh38:
- Chr17:42536444
| NAGLU | A58P | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688319-40688320
- GRCh38:
- Chr17:42536301-42536302
| NAGLU | V12fs | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695741
- GRCh38:
- Chr17:42543723
| NAGLU | S573G | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases
| Uncertain significance (Jun 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40695622
- GRCh38:
- Chr17:42543604
| NAGLU | R533Q | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695564
- GRCh38:
- Chr17:42543546
| NAGLU | R514C | Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B
| Uncertain significance (Mar 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40692985
- GRCh38:
- Chr17:42540967
| NAGLU | N261S | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689442
- GRCh38:
- Chr17:42537424
| NAGLU | T137M | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689478
- GRCh38:
- Chr17:42537460
| NAGLU | R149L | not provided, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
| Uncertain significance (Feb 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40690770
- GRCh38:
- Chr17:42538752
| NAGLU | T254I | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688316
- GRCh38:
- Chr17:42536298
| NAGLU | A9V | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688639
- GRCh38:
- Chr17:42536621
| NAGLU | V117L | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695372
- GRCh38:
- Chr17:42543354
| NAGLU | Q450E | Inborn genetic diseases, Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V
| Uncertain significance (Jun 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40695278
- GRCh38:
- Chr17:42543260
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693188
- GRCh38:
- Chr17:42541170
| NAGLU | A329T | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693197
- GRCh38:
- Chr17:42541179
| NAGLU | T332A | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688482
- GRCh38:
- Chr17:42536464
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695688
- GRCh38:
- Chr17:42543670
| NAGLU | A555V | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688525
- GRCh38:
- Chr17:42536507
| NAGLU | G79S | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695913
- GRCh38:
- Chr17:42543895
| NAGLU | V630G | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690747
- GRCh38:
- Chr17:42538729
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695532
- GRCh38:
- Chr17:42543514
| NAGLU | N503S | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693165
- GRCh38:
- Chr17:42541147
| NAGLU | S321F | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695694
- GRCh38:
- Chr17:42543676
| NAGLU | R557H | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40696078
- GRCh38:
- Chr17:42544060
| NAGLU | S685T | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690468
- GRCh38:
- Chr17:42538450
| NAGLU | P215S | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695912
- GRCh38:
- Chr17:42543894
| NAGLU | V630I | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690768
- GRCh38:
- Chr17:42538750
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689485
- GRCh38:
- Chr17:42537467
| NAGLU | E151D | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695939
- GRCh38:
- Chr17:42543921
| NAGLU | E639Q | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690789
- GRCh38:
- Chr17:42538771
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695687
- GRCh38:
- Chr17:42543669
| NAGLU | A555T | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690746
- GRCh38:
- Chr17:42538728
| NAGLU | A246E | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688295
- GRCh38:
- Chr17:42536277
| NAGLU | E2G | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40696149
- GRCh38:
- Chr17:42544131
| NAGLU | V709I | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688334
- GRCh38:
- Chr17:42536316
| NAGLU | L15P | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695728
- GRCh38:
- Chr17:42543710
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40696239
- GRCh38:
- Chr17:42544221
| NAGLU | V739M | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695512
- GRCh38:
- Chr17:42543494
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695565
- GRCh38:
- Chr17:42543547
| NAGLU | R514H | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:40693052
- GRCh38:
- Chr17:42541034
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Nov 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695506
- GRCh38:
- Chr17:42543488
| NAGLU | W494* | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695044
- GRCh38:
- Chr17:42543026
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Pathogenic (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690734
- GRCh38:
- Chr17:42538716
| NAGLU | L242P | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689489
- GRCh38:
- Chr17:42537471
| NAGLU | E153* | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688525
- GRCh38:
- Chr17:42536507
| NAGLU | G79C | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688434
- GRCh38:
- Chr17:42536416
| NAGLU | F48L | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Pathogenic (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688402
- GRCh38:
- Chr17:42536384
| NAGLU | R38W | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V, Inborn genetic diseases, not provided | Pathogenic/Likely pathogenic (Nov 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:40688410
- GRCh38:
- Chr17:42536392
| NAGLU | | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Likely benign (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690488
- GRCh38:
- Chr17:42538470
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695761-40695763
- GRCh38:
- Chr17:42543743-42543745
| NAGLU | R580del | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689497
- GRCh38:
- Chr17:42537479
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40692983
- GRCh38:
- Chr17:42540965
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40690413
- GRCh38:
- Chr17:42538395
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695245
- GRCh38:
- Chr17:42543227
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40693089
- GRCh38:
- Chr17:42541071
| NAGLU | L296M | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40689481
- GRCh38:
- Chr17:42537463
| NAGLU | W150* | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Pathogenic (Apr 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40695359
- GRCh38:
- Chr17:42543341
| NAGLU | | Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis, MPS-III-B | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:40688346
- GRCh38:
- Chr17:42536328
| NAGLU | G19E | Mucopolysaccharidosis, MPS-III-B, Charcot-Marie-Tooth disease axonal type 2V | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |